Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: Implications for WT1-based cancer therapeutics.
Borbulevych, O.Y., Do, P., Baker, B.M.(2010) Mol Immunol 47: 2519-2524
- PubMed: 20619457 
- DOI: 10.1016/j.molimm.2010.06.005
- Primary Citation of Related Structures:  
3HPJ, 3MYJ - PubMed Abstract: 
Presentation of peptides by class I or class II major histocompatibility complex (MHC) molecules is required for the initiation and propagation of a T cell-mediated immune response. Peptides from the Wilms Tumor 1 transcription factor (WT1), upregulated in many hematopoetic and solid tumors, can be recognized by T cells and numerous efforts are underway to engineer WT1-based cancer vaccines ...